Assenagon Asset Management S.A. Keros Therapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 07, 2025	BUY	$13.34 - $16.05 $2.08 Million - $2.51 Million	156,221 Added 154.22%	257,518 $4.07 Million
Q2 2025 Jul 11, 2025	BUY	$9.55 - $15.11 $347,238 - $549,399	36,360 Added 55.99%	101,297 $1.35 Million
Q4 2024 Jan 14, 2025	SELL	$15.64 - $70.0 $2.48 Million - $11.1 Million	-158,767 Reduced 70.97%	64,937 $1.03 Million
Q3 2024 Oct 23, 2024	BUY	$41.68 - $58.07 $8.3 Million - $11.6 Million	199,245 Added 814.61%	223,704 $13 Million
Q2 2024 Jul 18, 2024	BUY	$44.58 - $66.89 $1.09 Million - $1.64 Million	24,459 New	24,459 $1.12 Million

167

35.2M

574K

325K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $445M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.